Skip to main content
Pharmaron Beijing Co., Ltd logo

Pharmaron Beijing Co., Ltd — Investor Relations & Filings

Ticker · 3759 ISIN · CNE100003PG4 HKEX Professional, scientific and technical activities
Open in API
Filings indexed 991 across all filing types
Latest filing 2021-06-09 Regulatory Filings
Country HK Hong Kong
Listing HKEX 3759

About Pharmaron Beijing Co., Ltd

http://www.pharmaron.com

Pharmaron is a premier life science service provider and a comprehensive Contract Research and Manufacturing Organization (CRO/CDMO). The company delivers integrated research, development, and manufacturing capabilities across the entire drug development continuum, encompassing discovery, preclinical testing, clinical trials, and commercialization. Pharmaron's service portfolio supports diverse modalities, including small molecules, biologics, and advanced therapeutics such as cell and gene therapy (CGT) products. It partners with pharmaceutical, biotechnology, and medical device companies globally to advance their R&D pipelines.

Recent filings

Filing Released Lang Actions
An announcement has just been published by the issuer in the Chinese section of this website, a corresponding version of which may or may not be published in this section
Regulatory Filings Classification · 95% confidence The document is extremely short (242 characters) and serves as a notification that an announcement has been published elsewhere on the website. It does not contain financial data, meeting details, or specific corporate actions, but rather acts as a pointer to another document. Per the 'Menu vs Meal' rule, this is a Report Publication Announcement.
2021-06-09 English
An announcement has just been published by the issuer in the Chinese section of this website, a corresponding version of which may or may not be published in this section
Regulatory Filings Classification · 95% confidence The document is extremely short (242 characters) and serves as a notification that an announcement has been published elsewhere on the website. It does not contain financial data, meeting details, or specific corporate actions, but rather acts as a pointer to another document. Per the 'Menu vs Meal' rule, this is a Report Publication Announcement.
2021-06-09 English
An announcement has just been published by the issuer in the Chinese section of this website, a corresponding version of which may or may not be published in this section
Regulatory Filings Classification · 95% confidence The document is extremely short (242 characters) and serves as a notification that an announcement has been published elsewhere on the website. It does not contain financial data, meeting details, or specific corporate actions, but rather acts as a pointer to another document. Per the 'Menu vs Meal' rule, this is a Report Publication Announcement.
2021-06-09 English
PROPOSED REDUCTION OF REGISTERED CAPITAL AND PROPOSED AMENDMENTS TO THE ARTICLES OF ASSOCIATION
Regulatory Filings Classification · 95% confidence The document is an announcement from Pharmaron Beijing Co., Ltd. regarding a proposed reduction of registered capital and amendments to the Articles of Association. It details the Board's proposal to repurchase and cancel restricted shares, reduce registered capital, and amend the Articles accordingly. The document mentions that a circular with more details will be sent to shareholders. The text is relatively short (3551 characters) and serves as a notification of proposed corporate actions rather than a full report or detailed financial disclosure. It does not contain financial statements or detailed analysis but rather informs shareholders of upcoming proposals and changes. This fits the category of a Regulatory Filing (RNS) as it is a general regulatory announcement that does not fit into more specific categories like capital changes (SHA) because it is a proposal and notification rather than a completed capital change, nor is it a full report or presentation.
2021-06-09 English
(1) PROPOSED ADOPTION OF THE 2021 RESTRICTED A SHARE INCENTIVE SCHEME AND THE ASSESSMENT MANAGEMENT MEASURES&#x3b; (2) PROPOSED ISSUE AND GRANT OF THE NEW A SHARES UNDER THE 2021 RESTRICTED A SHARE IN
Capital/Financing Update Classification · 95% confidence The document is an announcement regarding the proposed adoption of a restricted share incentive scheme, including details about the scheme, participants, grant price, and related corporate governance matters. It discusses the proposal to be approved at an Extraordinary General Meeting (EGM) and includes regulatory references to listing rules and securities laws. The content is focused on the proposal and authorization for a share incentive plan, not the actual issuance or financial results. It is a detailed announcement about capital structure changes related to share incentives, specifically the issuance and grant of new shares under a specific mandate. This fits the category of Capital/Financing Update (CAP), as it involves updates on company fundraising and capital structure changes through share grants under an incentive scheme. The document is lengthy and detailed, not a brief notice or a report publication announcement, and it is not a full financial report or management discussion. Therefore, the appropriate classification is CAP with high confidence.
2021-06-09 English
PROPOSED ISSUE OF (i) US$300.0 MILLION ZERO COUPON CONVERTIBLE BONDS DUE 2026 AND (ii) RMB1,916.0 MILLION US$ SETTLED ZERO COUPON CONVERTIBLE BONDS DUE 2026
Capital/Financing Update Classification · 100% confidence The document is an announcement regarding the proposed issuance of convertible bonds by Pharmaron Beijing Co., Ltd. It details the terms of the bonds, subscription agreement, conditions precedent, and related approvals. The text includes information about the bond amounts, conversion prices, use of proceeds, and regulatory approvals. It is clearly an update on the company's capital raising activities through bond issuance. The document is lengthy (15,000 characters) and contains substantive details about the financing transaction, not just a brief notice or a report publication announcement. Therefore, it fits the category of Capital/Financing Update (CAP).
2021-06-09 English

Browse filings by year

8 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.